Immunotherapy for Renal-Cell Carcinoma Saves Lives Immunotherapy for Renal-Cell Carcinoma Saves Lives
A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 22, 2024 Category: Consumer Health News Tags: Hematology-Oncology Clinical Summary Source Type: news
Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
THURSDAY, April 18, 2024 -- For patients with clear-cell renal cell carcinoma, adjuvant pembrolizumab is associated with a significant and clinically meaningful improvement in overall survival, according to a study published in the April 18 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2024 Category: Pharmaceuticals Source Type: news
Honing treatment for advanced kidney cancer
A new Yale-led study identified molecular subgroups of common kidney cancer tumors to better understand how their makeup might affect treatment responses. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 5, 2024 Category: Universities & Medical Training Source Type: news
Could machine learning help predict outcomes in kidney cancer treatment?
A new Yale-led study identified molecular subgroups of common kidney cancer tumors to better understand how their makeup might affect treatment responses. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 5, 2024 Category: Universities & Medical Training Source Type: news
Mayo Clinic Minute: Advances in treating kidney cancer
Kidney cancer is one the most common cancers in the U.S., with over 81,000 new diagnoses in 2023 alone. Mayo Clinic sees a high volume of kidney cancer cases and is among the most experienced institutions in treating kidney tumors. In this Mayo Clinic Minute, Dr. Aaron Potretzke, a Mayo Clinic urologist, explains how advances in diagnostics and treatment have made kidney cancer more treatable than ever before. Watch: The Mayo Clinic Minute https://youtu.be/60YawJiXabU Journalists:… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 4, 2024 Category: Databases & Libraries Source Type: news
Diagnose Left Flank Pain in a 61-Year-Old Man Diagnose Left Flank Pain in a 61-Year-Old Man
Are you familiar with the presentation, differential diagnosis, and workup for renal cell carcinoma? Dr Karl J. D ' Silva provides a brief guide.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Wilms tumor: Kidney cancer in children
While kidney cancer is rare in children, Wilms tumor is the most common type found in kids, with between 500 and 600 children diagnosed annually in the U.S. The disease most often affects kids ages 3 to 4. Thanks to advances in treatments over the past several decades, survival rates from this rare cancer have improved significantly. Developing a treatment plan customized for each child with Wilms tumor has also helped to improve the prognosis for children… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 24, 2024 Category: Databases & Libraries Source Type: news
How to Manage Anxiety and Depression When You Have Kidney Cancer
When Katie Coleman was diagnosed at age 29 with a softball-sized tumor on her right kidney and a host of smaller growths in her liver, she was stunned. That astonishment quickly gave way to feelings of hopelessness. “I felt like my entire world was being pulled out from under me,” Coleman, now 32, says. “I went into a very dark spiral.”
Though her surgeon removed all the tumors, it wasn’t clear what her long- or even short- term prognosis was. What she found on the internet just freaked her out more. “One night I spiraled so deep I didn’t know whether life was worth living anymo...
Source: TIME: Health - March 22, 2024 Category: Consumer Health News Authors: Linda Carroll Tags: Uncategorized freelance healthscienceclimate Source Type: news
'I'm a doctor - these are the three most common red flag symptoms of hidden kidney cancer'
Kidney cancer claims around 13,300 new victims in the UK every year, that's 36 newly diagnosed patients every day. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2024 Category: Consumer Health News Source Type: news
Understanding kidney cancer
March is National Kidney Month, which makes this a good time to learn about kidney cancer. Kidney cancer is cancer that begins in the kidneys, which are two bean-shaped organs, each about the size of your fist. They're behind your abdominal organs, with one kidney on each side of your spine. The kidneys remove waste from your blood and regulate a healthy balance between water, sodium and minerals in your bloodstream. Approximately 81,600 new cases… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 16, 2024 Category: Databases & Libraries Source Type: news
A Blood Test for Colon Cancer Shows Promise
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
[time-brightcove not-tgx=”true”]
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold stan...
Source: TIME: Health - March 14, 2024 Category: Consumer Health News Authors: Carla K. Johnson/AP Tags: Uncategorized healthscienceclimate wire Source Type: news
Adjuvant IO: Survival Advantage'Big News' in Renal Cancer Adjuvant IO: Survival Advantage'Big News' in Renal Cancer
A 40% reduced risk for death from renal cancer, as reported by KEYNOTE-564, tops Dr Brian Rini ' s list of takeaways from ASCO GU 2024. Also discussed are updates on doublet therapy in advanced disease.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
After SABR, 100% Local Control at 1 Year in Kidney Cancer After SABR, 100% Local Control at 1 Year in Kidney Cancer
Among patients with primary RCC who did not undergo surgery, SABR led to no local treatment failures at 1 year, new phase 2 data showed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
'I'm super fit and thought I was indestructible - then I was told I had kidney cancer'
Personal trainer Pete Webster wasn't too worried when he spotted blood in his urine, but his wife insisted he saw his GP - potentially saving his life. (Source: Daily Express - Health)
Source: Daily Express - Health - March 11, 2024 Category: Consumer Health News Source Type: news
Q & A: Immunotherapy in Renal Cell Carcinoma (RCC) Q & A: Immunotherapy in Renal Cell Carcinoma (RCC)
A collaboration and conversation between Medscape and Dr Karl D ' Silva on the impact of immunotherapy in renal cell carcinoma.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
